This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of complex pharmaceutical agents. Its structure, featuring a pyrimidinetrione core, makes it valuable in the development of drugs targeting neurological disorders, particularly those involving modulation of neurotransmitter systems. The presence of the amino and diphenylethyl groups enhances its ability to interact with specific biological receptors, making it a candidate for creating compounds with potential antiepileptic or anxiolytic properties. Additionally, its chiral centers allow for the exploration of enantioselective interactions, which is crucial in designing drugs with improved efficacy and reduced side effects. Researchers also investigate its use in developing enzyme inhibitors, leveraging its unique structure to bind selectively to target enzymes involved in disease pathways.